Ideas
Partners
Consultants
Calls
EU Projects
Blog NEW
- Europe towards City Innovation Hubs
  
  Written by Matteo Satta EU funding has always helped cities support their innovation processes, particularly on digital transformation and environment, but the approach is now moving toward a new ambitious […]
- Mistakes that Cities Should Be Avoiding in EU Projects
  
  By Matteo Satta Nowadays, we are seeing an increasing trend of people requesting to lower taxes and, as a result, public budgets. This leads many cities to try to find […]
- How a city can boost your Smart City project
  
  By Matteo Satta The commission has been heavily investing in pilot Smart City projects for a long time, but you may often have R&D or innovation projects pretending to have […]
- How to involve a city in your project? Here are a few tips.
  
  Article written by Matteo Satta (Smart) City projects are more and more funded by the European Commission, but consortia often struggle to get cities on board or really engage them. […]
- >> See all posts
Log In Sign Up

Want to see this project on homepage?
Propose a Picture

Mucus Permeating Nanoparticulate Drug Delivery Systems (ALEXANDER)
Start date: Apr 1, 2012, End date: Mar 31, 2016 PROJECT FINISHED

The objective of the ALEXANDER project is the identification of novel strategies (e.g., proteolytic enzyme strategy, thiomer strategy, zeta potential changing systems, SNEDDS strategy) and the optimization of existing strategies (e.g., disulfide breaking strategy and slippery surface strategy) for the efficient transport of nanocarriers through the mucus gel layer (e.g., intestinal, nasal, ocular, vaginal, buccal, pulmonary). In particular, R&D activities will be focused on the synthesis of functionalized nanocarriers capable of permeating the mucus gel layer and delivering their therapeutic payload to the epithelium. The nanocarriers will be characterized with respect to their physicochemical properties, ability to cross the mucus gel layer, in vitro and in vivo cytotoxicity. The potential of the developed nanocarriers as delivery systems for mucosal administration of macromolecules will be demonstrated via the oral delivery of peptides, oligosaccharides and oligonucleotides and the nasal delivery of a plasmid encoding for an antigen.

Promote here

Your project activity

European Projects, Clusters and Open Calls

Open Calls and Tenders
A privileged space to disseminate your open Call to the Up2Europe community
European Projects
Consortium looking for a way to reach a wider audience for their activities
Consulting Firms
Promote your consulting services to the right target